Expression of retinoic acid signaling components ADH7 and ALDH1A1 is reduced in aniridia limbal epithelial cells and a siRNA primary cell based aniridia model.


Journal

Experimental eye research
ISSN: 1096-0007
Titre abrégé: Exp Eye Res
Pays: England
ID NLM: 0370707

Informations de publication

Date de publication:
02 2019
Historique:
received: 09 05 2018
revised: 29 08 2018
accepted: 03 10 2018
pubmed: 8 10 2018
medline: 16 4 2019
entrez: 8 10 2018
Statut: ppublish

Résumé

PAX6-related Aniridia is a sight-threatening disease involving progression of secondary glaucoma and aniridia related keratopathy (ARK). Change or loss of limbal epithelial progenitors causes epithelial surface defects. We analyzed the effect of PAX6 on mRNA expression changes with a two-step approach, as follows. First, we sequenced mRNA from limbal epithelial cells isolated from controls and aniridia patients. Second, we confirmed the bioinformatics and literature-based result list for a small interfering RNA (siRNA)-based primary aniridia cell model (PAX6 knockdown). With this approach, we expected that the genes directly influenced by PAX6 would be distinguishable from those affected secondarily by the ARK disease state. Therefore, epithelial cells were isolated from the limbus region of two patients with aniridia and cultured in keratinocyte serum-free medium. Normal control cells were obtained from the limbus region of corneal donors. For the siRNA-based aniridia cell model, cells were transfected with Lipofectamine and 5 nM siRNA against PAX6 or control treatment. All cells were lysed to yield DNA, RNA, and protein. Reduction of PAX6 protein was assessed by western blot. Aniridia and control Poly-A-enriched RNA libraries were subjected to next-generation sequencing. The differential analysis was a combination of quantification with RSEM and differential tests with edgeR. Gene lists were filtered by comparison to NCBI GEO datasets, annotated with DAVID, and manually annotated using a literature search. Based on the resulting filtered gene list, qPCR primers were purchased, and candidate genes (TP63, ABCG2, ADH7, ALDH1A1, PITX1, DKK1, DSG1, KRT12, KRT3, KRT13, SPINK6, SPINK7, CTSV, SERPINB1) were verified by qPCR on the siRNA-based aniridia cell model. We identified genes that might be regulated by PAX6 and showed that SPINK7 mRNA, which codes for a protease inhibitor, is downregulated in patients as well as in our primary aniridia cell model. ALDH1A1 and AHD7 mRNA levels were reduced in limbal epithelial cells of aniridia patients, and both transcripts were downregulated by PAX6 knockdown in our cell model. This siRNA-based aniridia cell model is a valuable tool for confirming identified PAX6-affected genes that might promote ARK pathogenesis. The model recapitulated expression changes for SPINK7, ADH7, and ALDH1A1 that were also observed in patient samples. These results provide evidence that PAX6 might drive corneal epithelial differentiation by direct or indirect control of retinoic acid signaling processes through ADH7 and ALDH1A1.

Identifiants

pubmed: 30292490
pii: S0014-4835(18)30359-2
doi: 10.1016/j.exer.2018.10.002
pii:
doi:

Substances chimiques

PAX6 Transcription Factor 0
PAX6 protein, human 0
RNA, Messenger 0
RNA, Small Interfering 0
SPINK7 protein, human 0
Serine Peptidase Inhibitors, Kazal Type 0
Tretinoin 5688UTC01R
ADH7 protein, human EC 1.1.1.1
Alcohol Dehydrogenase EC 1.1.1.1
Aldehyde Dehydrogenase 1 Family EC 1.2.1
Aldehyde Dehydrogenase EC 1.2.1.3
ALDH1A1 protein, human EC 1.2.1.36
Retinal Dehydrogenase EC 1.2.1.36

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

8-17

Informations de copyright

Copyright © 2018 Elsevier Ltd. All rights reserved.

Auteurs

Lorenz Latta (L)

Department of Ophthalmology, Saarland University Medical Center, Homburg, Saar, Germany. Electronic address: lorenz.latta@uks.eu.

Karl Nordström (K)

Department of Genetics and Epigenetics, Saarland University, Saarbrücken, Germany.

Tanja Stachon (T)

Department of Ophthalmology, Saarland University Medical Center, Homburg, Saar, Germany.

Achim Langenbucher (A)

Institute of Experimental Ophthalmology, Saarland University, Homburg, Saar, Germany.

Fabian N Fries (FN)

Department of Ophthalmology, Saarland University Medical Center, Homburg, Saar, Germany.

Nóra Szentmáry (N)

Department of Ophthalmology, Saarland University Medical Center, Homburg, Saar, Germany; Department of Ophthalmology, Semmelweis University, Budapest, Hungary.

Berthold Seitz (B)

Department of Ophthalmology, Saarland University Medical Center, Homburg, Saar, Germany.

Barbara Käsmann-Kellner (B)

Department of Ophthalmology, Saarland University Medical Center, Homburg, Saar, Germany.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH